|
| N | % | |
| Age | Less than 60 | 6 | 37.5% |
| More than 60 | 10 | 62.5% | |
| Gender | Male | 10 | 62.5% |
| Female | 6 | 37.5% | |
| Tumor Size | Less than 5 | 7 | 43.8% |
| More than 5 | 9 | 56.3% | |
| Tumor Site | Proximal Colon | 11 | 68.8% |
| Distal/Rectum | 5 | 31.3% | |
| Tumor Grade | Well Differentiated | 3 | 18.8% |
| Moderately Differentiated | 8 | 50.0% | |
| Poorly Differentiated | 5 | 31.3% | |
| Depth of Invasion (pT) | T1 - T2 | 7 | 43.8% |
| T3 - T4 | 9 | 56.3% | |
| Lymph Node Involvement (nT) | Negative | 11 | 68.8% |
| Positive | 5 | 31.3% | |
| Lymph Node Metastasis (pM) | No Metastasis | 13 | 81.3% |
| Metastasis | 3 | 18.8% | |
| Distant Detastasis | No metastasis | 13 | 81.3% |
| metastasis | 3 | 18.8% | |
| TNM | Stage 1 - 2 | 8 | 50.0% |
| Stage 3 - 4 | 8 | 50.0% | |
| Mucinous Histology | No | 9 | 56.3% |
| Yes | 7 | 43.8% | |
| LVI* | Absent | 13 | 81.3% |
| Present | 3 | 18.8% | |
| KRAS | Negative | 8 | 50.0% |
| Positive | 8 | 50.0% | |
| NRAS | No Mutation | 12 | 75.0% |
| Mutation | 4 | 25.0% | |